TY  - JOUR
AU  - Martín-Escolano, Rubén
AU  - Aguilera-Venegas, Benjamín
AU  - Marín, Clotilde
AU  - Martín-Montes, Álvaro
AU  - Martín-Escolano, Javier
AU  - Medina-Carmona, Encarnación
AU  - Arán, Vicente J
AU  - Sánchez-Moreno, Manuel
PY  - 2018
DO  - 10.1002/cmdc.201800512
UR  - http://hdl.handle.net/10668/12822
T2  - ChemMedChem
AB  - Chagas disease, a neglected tropical disease caused by infection with the protozoan parasite Trypanosoma cruzi, is a potentially life-threatening illness that affects 5-8 million people in Latin America, and more than 10 million people worldwide. It...
LA  - en
KW  - Chagas disease
KW  - Trypanosoma cruzi
KW  - antiprotozoal agents
KW  - drug discovery
KW  - nitroheterocycles
KW  - Animals
KW  - Chagas Disease
KW  - Chlorocebus aethiops
KW  - DNA
KW  - Enzyme Inhibitors
KW  - Ethylamines
KW  - Female
KW  - Indazoles
KW  - Membrane Potential, Mitochondrial
KW  - Mice, Inbred BALB C
KW  - Neglected Diseases
KW  - RNA
KW  - Superoxide Dismutase
KW  - Trypanocidal Agents
KW  - Trypanosoma cruzi
KW  - Vero Cells
TI  - Synthesis and Biological in vitro and in vivo Evaluation of 2-(5-Nitroindazol-1-yl)ethylamines and Related Compounds as Potential Therapeutic Alternatives for Chagas Disease.
TY  - research article
VL  - 13
ER  -